{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:35:17Z","timestamp":1793406917016,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T00:00:00Z","timestamp":1590105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ajoc.2020.100755","type":"journal-article","created":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T11:47:33Z","timestamp":1590234453000},"page":"100755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Treatment of periocular basal cell carcinoma with neoadjuvant vismodegib"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6366-6721","authenticated-orcid":false,"given":"Maxwell G.","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke B.","family":"Potts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan H.","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ajoc.2020.100755_bib1","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nrc2503","article-title":"Basal cell carcinomas: attack of the hedgehog","volume":"8","author":"Journal Article","year":"2008","journal-title":"Nat Rev Canc"},{"issue":"2","key":"10.1016\/j.ajoc.2020.100755_bib2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/bjd.15321","article-title":"Epidemiology of basal cell carcinoma: scholarly review","volume":"177","author":"Journal Article","year":"2017","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.ajoc.2020.100755_bib3","first-page":"133","article-title":"Role of vismodegib in the management of advanced periocular basal cell carcinoma","volume":"23","author":"Journal Article","year":"2016","journal-title":"Canc contr"},{"issue":"23","key":"10.1016\/j.ajoc.2020.100755_bib4","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1113713","article-title":"Efficacy and safety of vismodegib in advanced basal-cell carcinoma","volume":"366","author":"Journal Article","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajoc.2020.100755_bib5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ajo.2019.06.027","article-title":"A new paradigm in the treatment of advanced periocular basal cell carcinoma?","volume":"206","author":"Unsworth","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajoc.2020.100755_bib6","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/bjophthalmol-2018-312277","article-title":"Ocular preservation with neoadjuvant vismodegib in patients with locally advanced periocular basal cell carcinoma","volume":"103","author":"Sagiv","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajoc.2020.100755_bib7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2147\/CCID.S101330","article-title":"Spotlight on vismodegib in the treatment of basal cell carcinoma: an evidence-based review of its place in therapy","volume":"10","author":"Journal Article","year":"2017","journal-title":"Clin Cosmet Invest Dermatol"},{"issue":"5268","key":"10.1016\/j.ajoc.2020.100755_bib8","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.272.5268.1668","article-title":"Human homolog of patched, a candidate gene for the basal cell nevus syndrome","volume":"272","author":"Johnson","year":"1996","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.ajoc.2020.100755_bib9","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0092-8674(00)81268-4","article-title":"Mutations of the human homolog of drosophila patched in the nevoid basal cell carcinoma syndrome","volume":"85","author":"Hahn","year":"1996","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ajoc.2020.100755_bib10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/1758834016653605","article-title":"Hedgehog pathway inhibition in advanced basal cell carcinoma: latest evidence and clinical usefulness","volume":"8","author":"Journal Article","year":"2016","journal-title":"Therapeut Adv Med Oncol"},{"issue":"6","key":"10.1016\/j.ajoc.2020.100755_bib11","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S1470-2045(15)70198-1","article-title":"Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial","volume":"16","author":"Journal Article","year":"2015","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ajoc.2020.100755_bib12","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ng.3525","article-title":"Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma","volume":"48","author":"Bonilla","year":"2016","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.ajoc.2020.100755_bib13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/jid.2013.276","article-title":"Mutational landscape of basal cell carcinomas by whole-exome sequencing","volume":"134","author":"Jayaraman","year":"2014","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.ajoc.2020.100755_bib14","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaad.2013.09.012","article-title":"Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib","volume":"70","author":"Journal Article","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.ajoc.2020.100755_bib15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/IOP.0000000000001166","article-title":"Neoadjuvant vismodegib and Mohs micrographic surgery for locally advanced periocular basal cell carcinoma","volume":"35","author":"Gonz\u00e1lez","year":"2019","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"6","key":"10.1016\/j.ajoc.2020.100755_bib16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/IOP.0000000000000388","article-title":"Efficacy of vismodegib (Erivedge) for basal cell carcinoma involving the orbit and periocular area","volume":"31","author":"Demirci","year":"2015","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"2","key":"10.1016\/j.ajoc.2020.100755_bib17","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ajo.2015.04.040","article-title":"Hedgehog pathway inhibition for locally advanced periocular basal cell carcinoma and basal cell nevus syndrome","volume":"160","author":"Ozgur","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajoc.2020.100755_bib18","doi-asserted-by":"crossref","first-page":"e1424","DOI":"10.1097\/GOX.0000000000001424","article-title":"Vismodegib for locally advanced periocular and orbital basal cell carcinoma: a review of 15 consecutive cases","volume":"5","author":"Wong","year":"2017","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"12","key":"10.1016\/j.ajoc.2020.100755_bib19","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/jamaophthalmol.2013.5018","article-title":"Vismodegib for periocular and orbital basal cell carcinoma","volume":"131","author":"Gill","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajoc.2020.100755_bib20","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1001\/jamaophthalmol.2013.4430","article-title":"Vismodegib as eye-sparing adjuvant treatment for orbital basal cell carcinoma","volume":"131","author":"Kahana","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajoc.2020.100755_bib21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ajo.2019.04.013","article-title":"Efficacy of vismodegib for the treatment of orbital and advanced periocular basal cell carcinoma","volume":"207","author":"Eiger-Moscovich","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajoc.2020.100755_bib22","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/jamadermatol.2013.1798","article-title":"New onset of keratoacanthomas after vismodegib treatment for locally advanced basal cell carcinomas: a report of 2 cases","volume":"149","author":"Aasi","year":"2013","journal-title":"JAMA Dermatol"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993620301067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993620301067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:58:46Z","timestamp":1762527526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993620301067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":22,"alternative-id":["S2451993620301067"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2020.100755","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of periocular basal cell carcinoma with neoadjuvant vismodegib","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2020.100755","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100755"}}